dc.creatorHernando, Víctor
dc.creatorInserte, Javier
dc.creatorSartório, Carmem Luíza
dc.creatorParra, Víctor M.
dc.creatorPoncelas-Nozal, Marcos
dc.creatorGarcia-Dorado, David
dc.date.accessioned2019-03-11T13:00:04Z
dc.date.available2019-03-11T13:00:04Z
dc.date.created2019-03-11T13:00:04Z
dc.date.issued2010
dc.identifierJournal of Molecular and Cellular Cardiology, Volumen 49, Issue 2, 2018, Pages 271-279
dc.identifier00222828
dc.identifier10.1016/j.yjmcc.2010.02.024
dc.identifierhttps://repositorio.uchile.cl/handle/2250/165016
dc.description.abstractCalpains contribute to reperfusion-induced myocardial cell death. However, it remains controversial whether its activation occurs during ischemia or reperfusion. We investigated the regulation and time-course of calpain activation secondary to transient ischemia and the efficacy of its inhibition at reperfusion as a therapeutic strategy to limit infarct size. In isolated rat hearts (Sprague-Dawley), ischemia induced a time-dependent translocation of m-calpain to the membrane that was not associated with calpain activation as assessed by proteolysis of its substrate α-fodrin. Translocation of calpain was dependent on Ca2+ entry through reverse mode Na+/Ca2+-exchange and was independent of acidosis. Calpain activation occurred during reperfusion, but only after intracellular pH (pHi) normalization, and was not prevented by inhibiting its translocation during ischemia with methyl-β-cyclodextrin. The intravenous infusion of MDL-28170 in an in vivo rat model with transient coronary occlusio
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceJournal of Molecular and Cellular Cardiology
dc.subjectCalcium
dc.subjectCalpains
dc.subjectInfarct
dc.subjectIschemia
dc.subjectPH
dc.subjectReperfusion injury
dc.titleCalpain translocation and activation as pharmacological targets during myocardial ischemia/reperfusion
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución